Advanced Heart Failure and Transplant Cardiology · Plano, TX
NPI
1619235322
Since 2012
Specialty
Advanced Heart Failure and Transplant Cardiology
Code 207RA0001X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
6601 Preston Rd
Plano, TX, 75024
Phone (469) 800-6300
Groups this clinician bills Medicare through
Medicare paid, 2024
$136K
2,002 services
Medicare patients, 2024
405
Average age 74
Drug cost, 2024
$2.1M
2,149 prescriptions
Company payments, 2025
$106K
From 18 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Aasim Afzal was code 99233 (hospital e&m - subsequent), 378 times for 118 patients. In total Aasim Afzal billed 2,002 services in 62 codes, and Medicare paid $136K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2023-02-15.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 99233 Hospital E&M - Subsequent | Facility | 378 | 118 | $89.75 | $34K |
| 99215 Office E&M - Established | Facility | 194 | 115 | $101.12 | $20K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Facility | 187 | 113 | $12.03 | $2,249 |
| 93750 External Electrocardiographic Monitoring | Facility | 155 | 41 | $29.71 | $4,604 |
| 99291 Critical Care E&M | Facility | 147 | 46 | $161.34 | $24K |
| 99215 Office E&M - Established | Office | 110 | 54 | $128.57 | $14K |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 106 | 55 | $12.09 | $1,282 |
| 93306 Echocardiography (TTE/TEE) | Facility | 81 | 78 | $48.11 | $3,897 |
| 93000 Electrocardiogram | Office | 65 | 40 | $10.45 | $679 |
| 93308 Echocardiography (TTE/TEE) | Facility | 59 | 41 | $18.66 | $1,101 |
| 93325 Echocardiography (TTE/TEE) | Facility | 45 | 34 | $2.31 | $104 |
| 93321 Echocardiography (TTE/TEE) | Facility | 44 | 31 | $5.36 | $236 |
| 93005 Electrocardiogram | Office | 40 | 30 | $4.03 | $161 |
| 93010 Electrocardiogram | Office | 36 | 30 | $5.12 | $184 |
| 99232 Hospital E&M - Subsequent | Facility | 34 | 23 | $56.37 | $1,917 |
By year: 2022 $149K for 1,919 services; 2023 $160K for 2,123 services; 2024 $136K for 2,002 services.
Medicare prescription drug claims, 2024
In 2024, the drug Aasim Afzal prescribed most often to Medicare patients was Spironolactone, with 202 prescriptions and refills. In total Aasim Afzal wrote 2,149 Medicare prescriptions that cost $2.1M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Spironolactone Generic | 202 | 501 | 77 | $1,530 |
| Entresto Sacubitril/Valsartan | 144 | 323 | 47 | $195K |
| Metoprolol Succinate Generic | 142 | 383 | 56 | $1,930 |
| Carvedilol Generic | 119 | 311 | 51 | $1,173 |
| Farxiga Dapagliflozin Propanediol | 107 | 241 | 34 | $127K |
| Furosemide Generic | 92 | 236 | 42 | $570 |
| Warfarin Sodium Generic | 91 | 226 | 37 | $812 |
| Losartan Potassium Generic | 72 | 202 | 30 | $431 |
| Hydralazine Hcl Generic | 58 | 126 | 20 | $709 |
| Vyndamax Tafamidis | 58 | 58 | Under 11 | $1.4M |
| Bumetanide Generic | 56 | 118 | 17 | $1,716 |
| Atorvastatin Calcium Generic | 55 | 155 | 27 | $584 |
| Torsemide Generic | 48 | 103 | 27 | $1,291 |
| Rosuvastatin Calcium Generic | 47 | 133 | 19 | $889 |
| Jardiance Empagliflozin | 46 | 100 | 20 | $55K |
Brand drugs: - claims; generic drugs: 1,612 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Aasim Afzal $106K ($106K in general payments such as food, travel and fees) from 18 companies. The largest payer was BridgeBio Pharma, Inc. with $39K.
| Company | Payments | Amount |
|---|---|---|
| BridgeBio Pharma, Inc. BBIO | 28 | $39K |
| Abiomed JNJ | 29 | $30K |
| Alnylam Pharmaceuticals Inc. ALNY | 21 | $27K |
| Abbott Laboratories ABT | 28 | $5,748 |
| AstraZeneca Pharmaceuticals LP AZN | 7 | $1,545 |
| CVRx, Inc. CVRX | 5 | $1,180 |
| Merck Sharp & Dohme LLC MRK | 9 | $195 |
| Edwards Lifesciences Corporation EW | 1 | $168 |
| Bayer Healthcare Pharmaceuticals Inc. BAYN.DE | 6 | $132 |
| Analog Devices Inc. | 3 | $123 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.